RxDoctor Payments Data

Lynn Wojtysiak

Physician Assistant · Bel Air, MDNPI 1992775670

Payments from drug & device makers

$5,688in general payments, 2019–2025

Across 285 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$1K
  • AstraZeneca$582
  • Boston Scientific$562
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$415
  • Johnson & Johnson$393
  • Boehringer Ingelheim$381
  • plus $2K from 24 others

What the payments were for

  • Travel & lodging$2895%
  • Food & beverage$5,28793%
  • Education$1132%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,688 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$85,778
XareltoRivaroxaban21$33,463
Metoprolol Succinate76$1,794
Ranolazine ErRanolazine14$1,603
Rosuvastatin Calcium67$1,485
Ezetimibe25$1,363
Atorvastatin Calcium73$1,096
ClopidogrelClopidogrel Bisulfate57$1,018
Amlodipine Besylate72$603
Losartan Potassium42$586
Metoprolol Tartrate83$540
Digoxin16$488
Spironolactone26$470
Lisinopril53$388
Furosemide44$291

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$334$85,77860 claims
Johnson & JohnsonXarelto$393$33,46321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Bel Air

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →